Rosacea

The National Rosacea Society has opened its applications for research funding as the grant program celebrates its 25th anniversary, according to a press release.

As the year comes to a close, Healio Dermatology has assembled this year’s top aesthetic and skincare articles.

The FDA has approved Emrosi for the treatment of rosacea in adults, Journey Medical Corporation announced in a press release.

A study on cancer-causing benzene in acne products was Healio Dermatology’s most-read article of October, with coverage from clinical meetings also garnering attention.

An anti-redness regimen comprised of a redness reducing serum, moisturizer and sunscreen improved the signs and symptoms of rosacea while maintaining excellent tolerability, according to a study.

ORLANDO — Patients with rosacea experienced an improvement in symptoms following cryomodulation, according to pilot study results presented at the American Society for Dermatologic Surgery Annual Meeting.

Topical microencapsulated benzoyl peroxide improved the skin microbiome and physical properties and clinical symptoms among patients with rosacea, according to results of a study published in Journal of Clinical and Aesthetic Dermatology.

Patients with rosacea have an increased risk for malignant melanoma, joint problems, metabolic disease and visual disturbances, according to a study.

Antihypertensive medications may lower patients’ risk for developing acne within 5 years of therapy initiation, according to a study.

Erenumab is potentially efficacious in treating chronic flushing and erythema associated with rosacea, according to a study.